My ePortfolio Register   

Expert prostate discussion: Clinical diagnostics, genomics, systemic and radiological treatment

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.06.17
Views: 1558
Rating:

Dr Chris Parker and Prof Charles Ryan

Dr Chris Parker (The Royal Marsden, London, UK) and Prof Charles Ryan (UCSF School of Medicine, San Francisco, USA) have an expert discussion summarising the practice changing data from ASCO 2017. They focus on aspects of clinical diagnostics, genomics, systemic and radiological treatment.

Prof Ryan discusses the significance of low serum androgen levels and the correlation with lower survival outcomes. The findings this this data may change future clinical trial stratification factors. The speakers share their thoughts on: sequencing treatments by measuring circulating cell-free DNA; treatment strategies for patients with BRCA2 mutations and other DRDs and their views on 36 months of ADT vs.18 months.

Watch the discussion of LATITUDE and STAMPEDE or read the news stories for more (LATITUDE / STAMPEDE)

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutical (A Johnson & Johnson Company).

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence